S3 E27, Terri Gaskell, Chief Technology Officer of Rinri Therapeutics

Terri Gaskell | CTO, Rinri TherapeuticsRestoring Hearing. Redefining Possibility.In this episode, I speak with Terri Gaskell, Chief Technology Officer at Rinri Therapeutics, about the revolutionary work her team is doing to treat sensorineural hearing loss through stem cell therapy.Terri shares her remarkable journey from academia to biotech, the real-world hurdles of early-stage leadership, and the power of staying grounded (even when things get weird, wild, or wonderfully promising).We talk science, strategy, identity, and authenticity — all wrapped up in a clinical trial story that just might restore hearing for those who’ve lost it.🎙️ This episode of She Leads Biotech is proudly sponsored by Phacilitate & Women in Advanced Therapies (WIAT).📌 Chapters / Timestamps:00:00 – Meet Terri Gaskell & the Rinri mission03:05 – The science behind restoring hearing via stem cells07:20 – From university spinout to clinical trials: how it all began11:40 – Navigating burnout & building balanced leadership14:30 – Why authenticity matters more than ever in biotech17:25 – Terri’s Women in Advanced Therapies experience19:40 – The highs, lows, and marigolds of team management22:55 – How academia prepared (and didn’t prepare) her for biotech26:15 – Advice for new biotech leaders: confidence vs competence29:30 – Rinri’s clinical pipeline and what’s next33:00 – Final reflections on purpose, progress, and patient impact#SheLeadsBiotech #TerriGaskell #RinriTherapeutics #HearingLoss #CellTherapy #BiotechLeadership #WomenInSTEM #RegenerativeMedicine #CNAInternationalUSA #SharronCoxStudio #WIAT #Phacilitate #LifeSciences